The First Question Everyone Asks
In my role coordinating device procurement for a large cardiology unit, the first question from administration is almost always the same: "What's the price?"
I get it. Budgets are tight. The margin for error is zero. But here's the thing: that seemingly simple question has led us down some expensive paths.
Earlier this year, we were in a bind. The OR needed a specific coronary stent for a complex case the next morning. The standard delivery window was 48 hours. We didn't have that. The vendor we'd used for years quoted a price that was, frankly, higher than a competitor's. The competitor promised they could get it to us in 24 hours. The price difference? About $200 per unit.
Looking back, I should have paid for the more expensive option and the expedited shipping from our trusted partner. At the time, the $200 savings and the promise of speed seemed like a no-brainer. It wasn't.
The competitor's device arrived on time. But the packaging was different, the deployment mechanism was unfamiliar to our lead interventionist, and the clinical support we usually rely on wasn't available. The case took 20 minutes longer than expected. Under fluoroscopy, that's time, and time is radiation exposure for the patient and the team.
The surprise wasn't a technical failure—the stent placed just fine. But the 'savings' evaporated. We had to pull a senior tech from another case to assist. The physician was visibly frustrated, and the team's confidence in the device was shaky for days. That two-week period while we 'monitored' outcomes was stressful.
I should add that the total cost of that single case—including the extra OR time, overtime pay, and the intangible cost of team morale—was higher than if we'd just paid the $200 premium and stuck with what we knew.
Never expected a "lowest bid" situation to cost us more than a premium option. Turns out, in a clinical setting, the cheapest device is rarely the most affordable.
What We Actually Pay For
Why does this matter? Because most procurement conversations are still framed around the unit price. The real cost drivers are hidden in plain sight.
Let me break that down. The invoice price is just the beginning. What I mean is that the 'cheapest' option isn't just about the sticker price—it's about the total cost including your clinical team's time spent managing unfamiliar products, the risk of procedural delays, the potential need for additional inventory, and the intangible cost of a surgeon's confidence being shaken during a critical case.
In my experience managing over 200 rush orders in the last five years, the lowest quote has cost us more in 60% of cases.
Consider this: a premium device from a leader like Boston Scientific often comes with dedicated in-room clinical support. That's not listed on the invoice, but it's a cost if it's missing. If your team has to waste 15 minutes figuring out a new device, what's that worth? If the case takes longer, what's the cost of the extra OR time? If a device has a slightly higher rate of a specific complication, even by 1%, what's the cost of that one additional intervention?
We had a case where a budget vendor's catheter had a 2% higher failure rate than our standard. On paper, that's a small number. But for every 100 procedures that use this catheter, we see two failures. Each failure requires a re-intervention. The direct cost of one re-intervention—including the device, OR time, and recovery—easily exceeds the savings we made on the other 99 catheters. That's not a gamble I want to take.
The question isn't if you're paying hidden costs. It's how much.
The Real Cost of 'Just Getting It There'
Now, let's talk about that emergency scenario. The one where you absolutely need a device by tomorrow morning.
In March 2024, we had a situation where a vendor's delivery was two hours late. We had a patient prepped, anesthesiologist waiting, and a surgeon who was about to cancel. The delay wasn't the device itself—it was that the vendor had a single point of failure in their logistics. When their truck broke down, we had no backup.
I've tested six different rush delivery models over the years. Here's what actually works: a partner with a diversified supply chain and clinical support that can adapt. A partner who doesn't just sell you a box, but helps you open it, inspect it, and get it sterile-ready. A partner who, when something goes sideways, has a plan B.
Hit 'confirm' on a rush order with a new vendor once and immediately thought 'did I make the right call?' Didn't relax until the device arrived and was tested. That anxiety is a cost, too.
The Solution Isn't a Price List
So, what's the answer? It's not simply to buy the most expensive option. That's lazy.
The answer is a value framework. In our department, we now use a Total Cost of Procedure (TCP) model. It isn't perfect, and it took us a year to implement, but it's changed how we think.
Here's what we look at:
- Purchase Price: The invoice total.
- Clinical Support: Is it included? What's the availability?
- Procedure Time: Does this device speed up or slow down the case?
- Complication Rate: The real-world data, not just marketing claims.
- Logistics Reliability: Can they handle a rush? What's their failure rate?
- Training Load: How much time does my team need to learn this?
This framework didn't come easily. We lost a contract once by trying to save 5%—(I really should document that story). But the result is that we now partner with companies like Boston Scientific who invest heavily in clinical support and innovation. Their portfolio is broad, which means they can often offer a solution even when the first choice isn't available. Their latest acquisitions (like Silk Road Medical) show they're thinking about the future of procedures, not just the price of today's box.
When I'm triaging an urgent request now, I don't just ask for the price. I ask: Do you have a clinical specialist available? What's your backup plan? Can your device match our current workflow?
The right device at the right time is a value. The cheapest device on a truck is just a problem waiting to happen.